Company: QLYS
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001107843-25-000031
Chunk: 184

Company: QUALYS, INC.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 184
---
$182,937 $(214)December 31, 2024Less than 12 months12 months or longerTotalFair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses(in thousands)Commercial paper$4,464 $(2)$— $— $4,464 $(2)Corporate bonds27,154 (171)672 (3)27,826 (174)U.S. Treasury and government agencies64,517 (221)— — 64,517 (221)Total$96,135 $(394)$672 $(3)$96,807 $(397)The Company considered the extent to which any unrealized losses on its marketable securities were driven by credit risk and other factors, including market risk, and if it is more-likely-than-not that the Company would have to sell the security before the recovery of the amortized cost basis. At June 30, 2025 and December 31, 2024, the unrealized losses related to its marketable securities were due to market factors other than credit. The Company does not believe the unrealized losses represent credit risk, and the Company does not intend to sell any of the securities in an unrealized loss position and it is not likely that the Company would be required to sell these securities before recovery of their amortized cost basis, which may be at maturity. Thus, no credit loss was recognized for the Company's marketable securities for the three and six months ended June 30, 2025 and 2024.The following summarizes the fair value of marketable securities by contractual maturity:June 30, 2025Amortized CostFair Value(in thousands)Due within One Year$216,880 $217,065 Due after One Year through Five Years247,636 248,272 Asset-backed securities2,877 2,907 Total$467,393 $468,244 Non-Marketable SecuritiesDuring the fiscal year ended December 31, 2018, the Company invested $2.5 million in preferred stock of a privately-held company. The fair value of the investment is not readily available, and there are no quoted market prices for the investment. The Company accounts for the investment at cost less impairment and will measure the investment at fair value when the Company identifies observable price changes. The investment is assessed for impairment whenever events or changes in circumstances indicate that the fair value of the investment is